(SUZ) Suzano Papel e Celulose - Ratings and Ratios

Exchange: NYSE • Country: Brazil • Currency: USD • Type: Common Stock • ISIN: US86959K1051

Pulp, Paper, Tissue, Biofuel, Power

Paper Products
Market Cap in USD: 11,850m

IPO / Inception: 1996-02-27
Return 12m vs S&P 500: -19.9%

EPS (Earnings per Share)

EPS CAGR: -21.36%
EPS Trend: -14.1%

Last SUE: -0.07
Qual. Beats: 0

Revenue

Rev. CAGR: 1.55%
Rev. Trend: 17.9%

Last SUE: 0.02
Qual. Beats: 0

Dividends

Dividend Yield	2.13%
Yield on Cost 5y	2.10%
Yield CAGR 5y	-29.93%
Payout Consistency	64.3%
Payout Ratio	4.7%

Risk via 5d forecast
Volatility	23.7%
Value at Risk 5%th	34.9%
Relative Tail Risk	-10.48%

Reward TTM
Sharpe Ratio	-0.21
Alpha	-14.64
CAGR/Max DD	0.04

Character TTM
Hurst Exponent	0.362
Beta	0.422
Beta Downside	0.372

Drawdowns 3y
Max DD	32.01%
Mean DD	16.61%
Median DD	19.42%

Description: SUZ Suzano Papel e Celulose January 02, 2026

Suzano S.A. (NYSE:SUZ) is a Brazil-based integrated pulp and paper producer that sells coated and uncoated printing-writing papers, paperboards, tissue, and market-fluff pulps worldwide. The firm operates two primary segments-Pulp, and Paper & Consumer Goods-and supplements its core business with activities ranging from biofuel production and port terminal operations to biotechnology, nanocrystalline pulp R&D, and forest restoration.

Key recent metrics: in 2023 Suzano generated roughly 13 million tons of pulp, delivering an EBITDA margin near 30 % and a net debt-to-EBITDA ratio of about 2.1×, reflecting a strong cash-flow profile. The company’s earnings are highly sensitive to the USD/BRL exchange rate and to global hardwood pulp prices, which have been driven upward by sustained demand for sustainable packaging in North America and Europe. Additionally, Suzano’s 2024 capital-expenditure plan includes a $1.5 billion investment in expanding its integrated forest estate, a move that aligns with ESG-focused procurement trends in the paper sector.

For a deeper, data-rich analysis of Suzano’s valuation and risk factors, you may want to explore the detailed dashboards on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (6.56b TTM) > 0 and > 6% of Revenue (6% = 3.07b TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA 2.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 57.16% (prev 45.18%; Δ 11.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.12 (>3.0%) and CFO 19.00b > Net Income 6.56b (YES >=105%, WARN >=100%)

Net Debt (83.97b) to EBITDA (30.51b) ratio: 2.75 <= 3.0 (WARN <= 3.5)

Current Ratio 3.20 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.24b) change vs 12m ago -1.27% (target <= -2.0% for YES)

Gross Margin 34.44% (prev 42.60%; Δ -8.16pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 32.23% (prev 27.86%; Δ 4.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.08 (EBITDA TTM 30.51b / Interest Expense TTM 6.42b) >= 6 (WARN >= 3)

Altman Z'' 2.94

(A) 0.18 = (Total Current Assets 42.58b - Total Current Liabilities 13.32b) / Total Assets 164.42b

(B) 0.16 = Retained Earnings (Balance) 26.38b / Total Assets 164.42b

(D) 0.39 = Book Value of Equity 46.63b / Total Liabilities 119.16b

Total Rating: 2.94 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 63.45

1. Piotroski 5.50pt

2. FCF Yield 3.38%

3. FCF Margin 10.57%

4. Debt/Equity 2.21

5. Debt/Ebitda 2.75

6. ROIC - WACC (= 6.04)%

7. RoE 16.52%

8. Rev. Trend 17.89%

9. EPS Trend -14.08%

What is the price of SUZ shares?

As of January 12, 2026, the stock is trading at USD 9.55 with a total of 2,044,972 shares traded.
Over the past week, the price has changed by +0.32%, over one month by +5.28%, over three months by +9.29% and over the past year by -3.08%.

Is SUZ a buy, sell or hold?

Suzano Papel e Celulose has received a consensus analysts rating of 4.60. Therefore, it is recommended to buy SUZ.

Strong Buy: 3
Buy: 2
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the SUZ price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	12.5	30.6%
Analysts Target Price	12.5	30.6%
ValueRay Target Price	9.7	1.2%

SUZ Fundamental Data Overview January 04, 2026

Market Cap BRL = 63.82b (11.85b USD * 5.3852 USD.BRL)
P/E Trailing = 9.7143
P/E Forward = 8.6356
P/S = 0.2315
P/B = 1.4289
Beta = 0.201
Revenue TTM = 51.18b BRL
EBIT TTM = 19.77b BRL
EBITDA TTM = 30.51b BRL
Long Term Debt = 89.17b BRL (from longTermDebt, last quarter)
Short Term Debt = 4.64b BRL (from shortTermDebt, last quarter)
Debt = 99.81b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 83.97b BRL (from netDebt column, last quarter)
Enterprise Value = 160.09b BRL (63.82b + Debt 99.81b - CCE 3.53b)
Interest Coverage Ratio = 3.08 (Ebit TTM 19.77b / Interest Expense TTM 6.42b)
EV/FCF = 29.60x (Enterprise Value 160.09b / FCF TTM 5.41b)
FCF Yield = 3.38% (FCF TTM 5.41b / Enterprise Value 160.09b)
FCF Margin = 10.57% (FCF TTM 5.41b / Revenue TTM 51.18b)
Net Margin = 12.82% (Net Income TTM 6.56b / Revenue TTM 51.18b)
Gross Margin = 34.44% ((Revenue TTM 51.18b - Cost of Revenue TTM 33.55b) / Revenue TTM)
Gross Margin QoQ = 30.44% (prev 35.26%)
Tobins Q-Ratio = 0.97 (Enterprise Value 160.09b / Total Assets 164.42b)
Interest Expense / Debt = 1.83% (Interest Expense 1.82b / Debt 99.81b)
Taxrate = 35.08% (1.06b / 3.02b)
NOPAT = 12.83b (EBIT 19.77b * (1 - 35.08%))
Current Ratio = 3.20 (Total Current Assets 42.58b / Total Current Liabilities 13.32b)
Debt / Equity = 2.21 (Debt 99.81b / totalStockholderEquity, last quarter 45.12b)
Debt / EBITDA = 2.75 (Net Debt 83.97b / EBITDA 30.51b)
Debt / FCF = 15.53 (Net Debt 83.97b / FCF TTM 5.41b)
Total Stockholder Equity = 39.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.13% (Net Income 6.56b / Total Assets 164.42b)
RoE = 16.52% (Net Income TTM 6.56b / Total Stockholder Equity 39.73b)
RoCE = 15.33% (EBIT 19.77b / Capital Employed (Equity 39.73b + L.T.Debt 89.17b))
RoIC = 9.67% (NOPAT 12.83b / Invested Capital 132.64b)
WACC = 3.64% (E(63.82b)/V(163.62b) * Re(7.47%) + D(99.81b)/V(163.62b) * Rd(1.83%) * (1-Tc(0.35)))
Discount Rate = 7.47% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.51%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈3.47b ; Y1≈2.28b ; Y5≈1.04b
Fair Price DCF = N/A (negative equity: EV 33.13b - Net Debt 83.97b = -50.84b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -14.08 | EPS CAGR: -21.36% | SUE: -0.07 | # QB: 0
Revenue Correlation: 17.89 | Revenue CAGR: 1.55% | SUE: 0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=0.89 | Chg30d=-0.190 | Revisions Net=-1 | Growth EPS=-59.5% | Growth Revenue=+14.1%

Additional Sources for SUZ Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle